Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CL King Downgrades CMC Materials to Neutral

CL King analyst David Silver downgrades CMC Materials (NASDAQ:CCMP) from Buy to Neutral.

byBenzinga Newsdesk

April 7, 2022

1 minute read

CL King analyst David Silver downgrades CMC Materials (NASDAQ:CCMP) from Buy to Neutral.

RBC Capital Maintains Outperform on Allogene Therapeutics, Lowers Price Target to $35

By Benzinga Newsdesk

Today, 4:52 AM

RBC Capital analyst Luca Issi maintains Allogene Therapeutics (NASDAQ:ALLO) with a Outperform and lowers the price target from $45 to $35.

ALLO

News

Pain Therapeutics, Inc. (Now Cassava Sciences) Granted U.S. Patent #11,385,221 Alzheimer’s disease assay in a living patient

By Charles Gross

Today, 4:52 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=4315&f=G&l=50&d=PTXT&p=87&S1=20220712&OS=20220712&RS=20220712

SAVA

Bitcoin Analysts React To Fed Rate Hike: Is A ‘Short Squeeze’ In Cards Above $40K Level?

By Shivdeep Dhaliwal

Today, 4:52 AM

On Wednesday, the U.S. Federal Reserve hiked the target fed funds rate by 0.25% to between 0.25% and 0.5%. This is the first such rate hike since 2018.

BTC